文献速递新生儿儿童神经与发育行为

新生儿戒断综合征严重程度指数可预测18月龄神经发育结局

Neonatal Abstinence Syndrome Severity Index Predicts 18-Month Neurodevelopmental Outcome in Neonates Randomized to Morphine or Methadone.
PubMed 文献 · J Pediatr · 2020-08-14

该随机临床试验纳入116名母亲使用美沙酮或丁丙诺啡的阿片暴露足月新生儿,通过聚类分析定义高/低NAS严重程度,发现高严重程度组住院时间、治疗时长及研究药物总剂量更高,18月龄时低严重程度组Bayley-III语言评分更高。

要点

  • 高NAS严重程度与更长的住院时间和治疗时长相关
  • 高严重程度组更可能接受苯巴比妥治疗和吗啡治疗
  • 低严重程度组18月龄Bayley-III语言评分更高

核心结论

  • 基于推测性指标的NAS严重程度指数可预测18月龄发育结局。

研究设计与样本

  • 多中心随机临床试验纳入116名阿片暴露足月新生儿,随机接受吗啡或美沙酮治疗,99名出院时完成NNNS评估,83名18月龄完成Bayley-III评估,77名完成CBCL评估。

主要发现

  • 高严重程度组较低严重程度组住院时间更长(P < .001)、因NAS住院时间更长(P < .001)、因NAS治疗持续时间更长(P < .001)、研究药物总剂量更高(P < .001)。
  • 高严重程度组更可能接受苯巴比妥(P < .001)、接受吗啡治疗(P = .020)及具有非典型NNNS特征(P = .005)。
  • 两组最大Finnegan评分无差异。
  • 18月龄未调整分析中,低严重程度组Bayley-III认知(P = .013)、语言(P < .001)、运动(P = .041)综合评分更高,CBCL总行为问题更少(P = .028)。
  • 调整分析后,Bayley-III语言综合评分差异仍存在(P = .013)。

临床怎么用

  • 临床可聚合NAS严重程度的推测性指标形成指数,以识别可能影响18月龄神经发育的高危新生儿。

局限性

  • 18月龄随访仅83/99(83.8%)完成Bayley-III评估,77/99(77.7%)完成CBCL评估,存在失访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop an index to determine which opioid-exposed neonates have the most severe neonatal abstinence syndrome (NAS). STUDY DESIGN: Full-term neonates with NAS (n = 116) from mothers maintained on methadone or buprenorphine were enrolled from 8 sites into a randomized clinical trial of morphine vs methadone. Ninety-nine (85%) were evaluated at hospital discharge using the NICU Network Neurobehavioral Scale (NNNS). At 18 months, 83 of 99 (83.8%) were evaluated with the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III), and 77 of 99 (77.7%) were evaluated with the Child Behavior Checklist (CBCL). RESULTS: Cluster analysis was used to define high (n = 21) and low (n = 77) NAS severity. Compared with infants in the low NAS severity cluster, infants in the high NAS severity cluster had a longer length of stay (P < .001), longer length of stay due to NAS (P < .001), longer duration of treatment due to NAS (P < .001), and higher total dose of the study drug (P < .001) and were more likely to have received phenobarbital (P < .001), to have been treated with morphine (P = .020), and to have an atypical NNNS profile (P = .005). The 2 groups did not differ in terms of maximum Finnegan score. At 18 months, in unadjusted analyses, compared with the high-severity cluster, the low-severity cluster had higher scores on the Bayley-III Cognitive (P = .013), Language (P < .001), and Motor (P = .041) composites and less total behavior problems on the CBCL (P = .028). In adjusted analyses, the difference in the Bayley-III Language composite remained (P = .013). CONCLUSIONS: Presumptive measures of NAS severity can be aggregated to develop an index that predicts developmental outcomes at age 18 months.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Flannery T, Davis JM, Czynski AJ, et al. Neonatal Abstinence Syndrome Severity Index Predicts 18-Month Neurodevelopmental Outcome in Neonates Randomized to Morphine or Methadone. J Pediatr. 2020. PMID: 32805259. doi:10.1016/j.jpeds.2020.08.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。